Summary of the COVID-19 briefing 22nd of July

22.07.2021 - 12:15
Mynd með færslu
 Mynd: Almannavarnir
Updated numbers are as follows: 78 cases diagnosed yesterday, 52 fully vaccinated, 5 received a first dose. 19 of those were in quarantine at the time of diagnosis.

Þórólfur Guðnason, Chief Epidemiologist, explained in the meeting the relation between the new mutation of the virus, known as delta variant, and the effectiveness of that vaccines against it. Because the protection is not as high as against other variants, we observe a surge in cases among vaccinated individuals.

Currently, there is one person hospitalised and six others under close supervision of the doctors. They might be also admitted to the hospital at some point. We can observe increase in the number of serious cases.

This month 236 sickened with COVID-19, 213 of them last week only. Most of those infected have been vaccinated, and of those largest group received Janssen vaccine.

The infections spread quickly in the society, which is in line with the character of the delta variant, which is much more infectious than the pervious mutations.

Persons who received the Janssen vaccine, will be offered a booster dose. Additional dose will also be offered to individuals who might have not developed sufficient immune response. Because the booster dose shouldn’t be admitted earlier than 4-6 weeks from the previous one, the next round of jabs will not be disposed before the end of August.

Þórólfur also reminds of the importance of the voluntary testing that he suggests to those with a family and friends’ network on the island who come from a trip abroad. He would like to see the residents returning from abroad keeping distance from the society until receiving a test result.

The Team wishes to remind that the situation will be dynamic as long as it is changing in the world.

As for now, the rules will not be changed. A letter with recommendations will be sent to the government and only then possible actions introduced.

Click to follow RÚV English on Facebook.